Skip to main content
. 2013 Sep 18;7:584. doi: 10.3389/fnhum.2013.00584

Table 1.

Description of patient sample.

Sample size 108
Age (years), M ± SD 57.58 ± 13.67
Male n (%) 62 (57.4)
LESION AGE*
6–12 months n (%) 15 (13.9)
1–2 years n (%) 11 (10.2)
>2 years n (%) 82 (75.9)
TYPE OF LESION n (%)*
Optic atrophy of unknown etiology 6 (5.6)
Glaucoma 34 (31.5)
AION 24 (22.2)
Optic neuritis 12 (11.2)
Optic nerve compression (tumor) 8 (7.4)
NAION 17 (15.7)
Multiple sclerosis with optic neuritis 1 (0.9)
Optic atrophy after optic disk swelling 3 (2.8)
Optic atrophy after papillitis 1 (0.9)
Optic atrophy after papilledema 1 (0.9)
Leber’s hereditary optic neuropathy 3 (2.8)
Stroke/thrombosis with optic atrophy 5 (4.6)
Congenital optic atrophy 3 (2.8)
AFFECTED EYES n (%)
Monocular impairment, one eye intact 41 (38.0)
Binocular impairment, both eyes defect 58 (53.7)
Binocular impairment, one eye blind 9 (8.3)
VISUAL PARAMETERS M  ± SD
Detection accuracy in HRP (%) 48.6 ± 27.7
Detection accuracy central 5° in HRP (%) 58.1 ± 28.3
Reaction time in HRP (ms) 532 ± 84
Foveal threshold (dB) in static perimetry 21.2 ± 8.9
Mean threshold (dB) in static perimetry 10.9 ± 6.4

* Because of dual diagnoses the sum of lesion age types and etiologies (%) is above 100%.